Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

06978 Immunotech Biopharm Ltd-B

4.0500.0000.00%
Closed 09/30 16:08 CCT
High
4.050
Open
4.050
Turnover
647.87K
Low
3.860
Pre Close
4.050
Volume
161.00K
Market Cap
2.08B
P/E(TTM)
Loss
52wk High
17.500
Shares
514.58M
P/E(Static)
Loss
52wk Low
3.210
Float Cap
2.08B
Bid/Ask %
27.78%
Historical High
22.450
Shs Float
514.58M
Volume Ratio
0.04
Historical Low
3.210
Dividend TTM
--
Div Yield TTM
--
P/B
2.60
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.03%
Amplitude
4.69%
Avg Price
4.024
Lot Size
1000
Float Cap
2.08B
Bid/Ask %
27.78%
Historical High
22.450
Shs Float
514.58M
Volume Ratio
0.04
Historical Low
3.210
Dividend TTM
--
P/B
2.60
Dividend LFY
--
Turnover Ratio
0.03%
Amplitude
4.69%
Avg Price
4.024
Lot Size
1000
Price Forecast

No Data

News

Comment

Company Overview More
Yongtai Biopharmaceutical Co., Ltd. is a Chinese investment holding company mainly engaged in the research, development, manufacture and commercialization of cellular immunity products for the treatment of cancer. Its main products are EAL, CAR-T cell series and TCR-T cell series. EAL is a multi-target cellular immunotherapy product. It also provides cell cryopreservation service. The company mainly does business in China.
CEO: Zheng Tan
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...